DrugPatentWatch Database Preview
Litigation Details for Osmotica Pharmaceutical US LLC v. Adamas Pharmaceuticals, Inc. (D. Del. 2018)
» See Plans and Pricing
Osmotica Pharmaceutical US LLC v. Adamas Pharmaceuticals, Inc. (D. Del. 2018)
| Docket | Start Trial | Date Filed | 2018-02-15 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | Plaintiff | Referred To | |
| Parties | VERTICAL PHARMACEUTICALS, LLC | ||
| Patents | 8,389,578; 8,741,343; 8,796,337; 8,889,740; 8,895,614; 8,895,615; 8,895,616; 8,895,617; 8,895,618; 9,867,791; 9,867,792; 9,867,793 | ||
| Attorneys | Adam Wyatt Poff | ||
| Firms | Young, Conaway, Stargatt & Taylor LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Osmotica Pharmaceutical US LLC v. Adamas Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is Start Trial .
Details for Osmotica Pharmaceutical US LLC v. Adamas Pharmaceuticals, Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-02-15 | 1 | claim of U.S. Patent Nos. 8,389,578 (“the ’578 patent”); 8,741,343 (“the ’343 patent”); 8,796,337 (“…now U.S. Patent No. 8,389,578. The ’578 patent claims the benefit to U.S. Provisional Patent Application…now U.S. Patent No. 8,389,578. The ’578 patent claims the benefit to U.S. Provisional Patent Application… now U.S. Patent No. 8,389,578. The ’578 patent claims benefit to U.S. Provisional Patent Application… now U.S. Patent No. 8,389,578. The ’578 patent claims benefit to U.S. Provisional Patent Application | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
